Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is 3.89x as of 2026-10-06T15:35:52.333Z.
Calculation as of: 2026-10-06T15:35:52.333Z.
Quote observation: 2026-10-06T15:34:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ade6551c806a0b8a23cc3b9f653dfce73cf5104c20f92b5c51aa4b81f5201f45
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
3.89x
SECTOR MEDIAN · HEALTHCARE
1.58x
median of 626 covered companies
CURRENT VS SECTOR MEDIAN
+146.20%
vs the sector median at left
BlossomHill Therapeutics, Inc.
Market Cap
$555.16M
EV/Assets Ratio
3.89x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$556.87M
EV/Assets Ratio
23.90x
TTM Avg
9.52x
3Y Avg
6.68x
5Y Avg
7.35x
Market Cap
$558.65M
EV/Assets Ratio
3.00x
TTM Avg
2.77x
3Y Avg
1.31x
5Y Avg
2.02x
Market Cap
$567.12M
EV/Assets Ratio
1.46x
TTM Avg
3.28x
3Y Avg
1.55x
5Y Avg
1.16x
Market Cap
$540.95M
EV/Assets Ratio
3.62x
TTM Avg
3.21x
3Y Avg
4.75x
5Y Avg
3.60x
Market Cap
$538.58M
EV/Assets Ratio
1.31x
TTM Avg
5.84x
3Y Avg
3.25x
5Y Avg
6.26x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BlossomHill Therapeutics, Inc. (BLSM) | $555.16M | 3.89x | N/A | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $556.87M | 23.90x | 9.52x | 6.68x | 7.35x |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $558.65M | 3.00x | 2.77x | 1.31x | 2.02x |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| CorMedix Inc. (CRMD)vs › | $566.03M | 0.50x | 1.12x | 3.33x | 2.77x |
| CytomX Therapeutics, Inc. (CTMX)vs › | $567.12M | 1.46x | 3.28x | 1.55x | 1.16x |
| Delcath Systems, Inc. (DCTH)vs › | $540.95M | 3.62x | 3.21x | 4.75x | 3.60x |
| Immix Biopharma, Inc. (IMMX)vs › | $538.58M | 1.31x | 5.84x | 3.25x | 6.26x |
| ProKidney Corp. (PROK)vs › | $538.01M | 1.87x | 0.64x | 0.45x | 3.05x |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $537.18M | 1.60x | 3.54x | 2.23x | 2.21x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
